Noile-Immune Biotech Inc. (TYO:4893)
Japan
· Delayed Price · Currency is JPY 169.00
+2.00 (1.20%)
Jun 27, 2025, 3:30 PM JST
Noile-Immune Biotech Market Cap
Noile-Immune Biotech has a market cap or net worth of 7.32 billion as of June 27, 2025. Its market cap has increased by 26.12% in one year.
Market Cap
7.32B
Enterprise Value
2.85B
Revenue
7.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
169.00
Market Cap Chart
Since June 28, 2023, Noile-Immune Biotech's market cap has decreased from 30.89B to 7.32B, a decrease of -76.31%. That is a compound annual growth rate of -51.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 7.32B | -0.59% |
| Dec 30, 2024 | 7.36B | -19.77% |
| Dec 29, 2023 | 9.17B | -70.30% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 12.48T |
| Takeda Pharmaceutical Company | 6,803.37B |
| Daiichi Sankyo Company | 6,158.09B |
| HOYA Corporation | 5,780.62B |
| Terumo | 3,955.08B |
| Otsuka Holdings | 3,748.64B |
| Astellas Pharma | 2,479.30B |
| Shionogi & | 2,165.85B |